Skeletal Muscle Insulin Resistance in Normoglycemic Subjects with a Strong Family History of Type 2 Diabetes is Associated with Decreased Insulin-Stimulated Insulin Receptor Substrate-1 Tyrosine Phosphorylation

Diabetes

Volumn 50, Issue 7-12, 2001, Pages 2572-2578

  Pratipanawatr, Wilailak ^a   Pratipanawatr, Thongchai ^a   Cusi, Kenneth ^a   Berria, Rachele ^a   Adams, John M ^a   Jenkinson, Christopher P ^a   Maezono, Katsumi ^a   DeFronzo, Ralph A ^a   Mandarino, Lawrence J ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1 PROTEIN; INSULIN RECEPTOR SUBSTRATE-1 PROTEIN; PHOSPHOPROTEIN; TYROSINE;

ADULT; ARTICLE; FEMALE; GENETICS; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN RESISTANCE; MALE; MEDICAL RECORD; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ADULT; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MEDICAL RECORDS; MUSCLE, SKELETAL; PHOSPHOPROTEINS; PHOSPHORYLATION; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; TYROSINE;

EID: 0035511730     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.11.2572     Document Type: Article

References (43)

1. DeFronzo RA: Lilly Lecture 1987: the triumvirate: beta-cell, muscle, liver; a collusion responsible for NIDDM. Diabetes 37:667-687, 1988
2. Kobberling J, Tillil H: Empirical risk figures for first-degree relatives of non-insulin dependent diabetics. In The Genetics of Diabetes Mellitus. Kobberling J, Tattersall R, Eds. London, Academic Press, 1982, p. 201-209
3. Barnett AH, Eff C, Leslie RDG, Pyke DA: Diabetes in identical twins: a study of 200 pairs. Diabetologia 20:87-93, 1981
4. Newman B, Selby JV, King MC, Slemenda C, Fabsitz R, Friedman GD: Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia 30:763-768, 1987
5. Perseghin G, Ghosh S, Gerow K, Shulman GI: Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. Diabetes 46:1001-1009, 1997
6. Groop L, Forsblom C, Lehtovirta M, Tuomi T, Karanko S, Nissen M, Ehrnstrom BO, Forsen B, Isomaa B, Snickars B, Taskinen MR: Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects. Diabetes 45:1585-1593, 1996
7. Gulli G, Ferrannini E, Stern M, Haffner S, DeFronzo RA: The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes 41:1575-1586, 1992
8. Vaag A, Henriksen JE, Beck-Nielsen H: Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest 89:782-788, 1992
9. Volk A, Renn W, Overkamp D, Mehnert B, Maerker E, Jacob S, Balletshofer B, Haring HU, Rett K: Insulin action and secretion in healthy, glucose tolerant first degree relatives of patients with type 2 diabetes mellitus: influence of body weight. Exp Clin Endocrinol Diabetes 107:140-147, 1999
10. Baier LJ, Permana PA, Traurig M, Dobberfuhl A, Wiedrich C, Sutherland J, Thuillez P, Luczy-Bachman G, Hara M, Horikawa Y, Hinokio Y, Hanson RL, Bogardus C: Mutations in the genes for hepatocyte nuclear factor (HNF)-1alpha, -4alpha, -1beta, and -3beta; the dimerization cofactor of HNF-1; and insulin promoter factor 1 are not common causes of early-onset type 2 diabetes in Pima Indians. Diabetes Care 23:302-304, 2000
11. Ilag LL, Tabaei BP, Herman WH, Zawacki CM, D'Souza E, Bell GI, Fajans SS: Reduced pancreatic polypeptide response to hypoglycemia and amylin response to arginine in subjects with a mutation in the HNF-4alpha/ MODY1 gene. Diabetes 49:961-968, 2000
12. Guazzini B, Gaffi D, Mainieri D, Multari G, Cordera R, Bertolini S, Pozza G, Meschi F, Barbetti F: Three novel missense mutations in the glucokinase gene (G80S; E221K; G227C) in Italian subjects with maturity-onset diabetes of the young (MODY) [Mutations in Brief no. 162]. Hum Mutat 12:136, 1998
13. Lehto M, Wipemo C, Ivarsson SA, Lindgren C, Lipsanen-Nyman M, Weng J, Wibell L, Widen E, Tuomi T, Groop L: High frequency of mutations in MODY and mitochondrial genes in Scandinavian patients with familial early-onset diabetes. Diabetologia 42:1131-1137, 1999
14. Miller SP, Anand GR, Karschnia EJ, Bell GI, LaPorte DC, Lange AJ: Characterization of glucokinase mutations associated with maturity-onset diabetes of the young type 2 (MODY-2): different glucokinase defects lead to a common phenotype. Diabetes 48:1645-1651, 1999
15. Chevre JC, Hani EH, Boutin P, Vaxillaire M, Blanche H, Vionnet N, Pardini VC, Timsit J, Larger E, Charpentier G, Beckers D, Maes M, Bellanne-Chantelot C, Velho G, Froguel P: Mutation screening in 18 Caucasian families suggest the existence of other MODY genes. Diabetologia 41: 1017-1023, 1998
16. Bogardus C, Lillioja S, Stone K, Mott D: Correlation between muscle glycogen synthase activity and in vivo insulin action in man. J Clin Invest 73:1185-1190, 1984
17. Beck-Nielsen H, Vaag A, Damsbo P, Handberg A, Nielsen O, Henriksen JE, Thye-Ronn P: Insulin resistance in skeletal muscles in patients with NIDDM. Diabetes Care 15:418-429, 1992
18. Kelley DE, Mokan M, Mandarino L: Intracellular defects in glucose metabolism in obese patients with non-insulin-dependent diabetes mellitus. Diabetes 41:698-706, 1992
19. Thorburn A, Gumbiner B, Bulacan F, Wallace P, Henry R: Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake. J Clin Invest 85:522-529, 1990
20. Jackson S, Bagstaff SM, Lynn S, Yeaman SJ, Turnbull DM, Walker M: Decreased insulin responsiveness of glucose uptake in cultured human skeletal muscle cells from insulin-resistant nondiabetic relatives of type 2 diabetic families. Diabetes 49:1169-1177, 2000
21. Cusi K, Maezono K, Osman A, Pendergrass M, Patti ME, Pratipanawatr T, DeFronzo RA, Kahn CR, Mandarino LJ: Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J Clin Invest 105:311-320, 2000
22. Krook A, Bjornholm M, Galuska D, Jiang XJ, Fahlman R, Myers MG, Wallberg-Henriksson H, Zierath JR: Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. Diabetes 49:284-292, 2000
23. Mandarino LJ, Wright K, Verity L, Nichols J, Bell J, Kolterman O, Beck-Nielsen H: Effect of insulin infusion on human skeletal muscle pyruvate dehydrogenase, phosphofructokinase and glycogen synthase. J Clin Invest 80:655-663, 1987
24. DeFronzo RA, Tobin J, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and insulin resistance. Am J Physiol 237: E214-E223, 1979
25. Steele R, Wall J, DeBodo R, Altszuler N: Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 187:15-24, 1956
26. Gelding SV, Coldham N, Niththyananthan R, Anyaoku V, Hohnston DG: Insulin resistance with respect to lipolysis in non-diabetic relatives of European patients with type 2 diabetes. Diabet Med 12:66-73, 1995
27. Jacob S, Machann J, Rett K, Brechtel K, Volk A, Renn W, Maerker E, Matthaei S, Schic KF, Claussen CD, Haring HU: Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes 48:1113-1119, 1999
28. Axelsen M, Smith U, Eriksson JW, Taskinen MR, Jansson PA: Postprandial hypertriglyceridemia and insulin resistance in normoglycemic first-degree relatives of patients with type 2 diabetes. Ann Intern Med 131:27-31, 1999
29. Balletshofer BM, Rittig K, Enderle MD, Volk A, Maerker E, Jacob S, Matthaei S, Rett K, Haring HU: Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation 101:1780-1784, 2000
30. Nyholm B, Porksen N, Juhl C, Gravholt CH, Butler PC, Weeke J, Veklhuis JD, Pincus S, Schmitz O: Assessment of insulin secretion in relatives of patients with type 2 (non-insulin-dependent) diabetes mellitus: evidence of early beta-cell dysfunction. Metabolism 49:896-905, 2000
31. Okada T, Kawano Y, Sakakibara T, Hazeki O, Ui M: Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes-studies with a selective inhibitor wortmannin. J Biol Chem 269:3568-3573, 1994
32. Sheperd P, Nave B, Siddle K: Insulin stimulation of glycogen synthesis and glycogen synthase activity is blocked by wortmannin and rapamycin in 3T3-L1 adipocytes. Biochem J 305:25-28, 1995
33. Yeh J, Gulve E, Rameh L, Birnbaum M: The effects of wortmannin on rat skeletal muscle. J Biol Chem 270:2107-2111, 1995
34. Myers MG, Mendez R, Shi P, Pierce JH, Rhoads R, White MF: The COOH-terminal tyrosine phosphorylation sites on IRS-1 bind SHP-2 and negatively regulate insulin signaling. J Biol Chem 273:26908-26914, 1998
35. Handberg A, Vaag A, Vinten J, Beck-Nielsen H: Decreased tyrosine kinase activity in partially purified insulin receptors from muscle of young, non-obese first degree relatives of patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36:668-674, 1993
36. DeFea K, Roth RA: Modulation of insulin receptor substrate-1 tyrosine phosphorylation and function by mitogen-activated protein kinase. J Biol Chem 272:31400-31406, 1997
37. Li J, DeFea K, Roth RA: Modulation of insulin receptor substrate-1 tyrosine phosphorylation by an Akt/phosphatidylinositol 3-kinase pathway. J Biol Chem 274:9351-9356, 1999
38. Eldar-Finkelman H, Krebs EG: Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action. Proc Natl Acad Sci U S A 94:9660-9664, 1997
39. Imai Y, Fusco A, Suzuki Y, Lesniak MA, D'Alfonso R, Sesti G, Bertoli A, Lauro R, Accili D, Taylor SI: Variant sequences of insulin receptor substrate-1 in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 79:1655-1658, 1994
40. Imai Y, Philippe N, Accili D, Taylor SI: Expression of variant forms of insulin receptor substrate-1 identified in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 82:4201-4207, 1997
41. Hitman GA, Hawrammi K, McCarthy MI, Viswanathan M, Snehalatha C, Ramachandran A, Tuomilehto J, Tuomilehto-Wolf E, Nissenen A, Pedersen O: Insulin receptor substrate-1 gene mutations in NIDDM: implication for the study of polygenic disease. Diabetologia 38:481-486, 1995
42. Armstrong M, Haldane F, Avery PJ, Mitcheson J, Stewart MW, Turnbull DM, Walker M: Relationship between insulin sensitivity and insulin receptor substrate-1 mutations in non-diabetic relatives of NIDDM families. Diabet Med 13:341-345, 1996
43. Nyholm B, Qu Z, Kaal A, Pedersen SB, Gravholt CH, Andersen JL, Saltin B, Schmitz O: Evidence of an increased number of type IIb muscle fibers in insulin-resistant first-degree relatives of patients with NIDDM. Diabetes 46:1822-1828, 1997